LBEL LEDERM 55plus JourSPF 15 Facial Treatment Against Advanced Signs of Aging Day – All Skin Types (Ventura International LTD.)
Welcome to the PulseAid listing for the LBEL LEDERM 55plus Jour drug offered from Ventura International LTD.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ventura International LTD. |
NON-PROPRIETARY NAME: | Avobenzone, Octisalate, Octocrylene, and Oxybenzone |
SUBSTANCE NAME: | AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2013-04-01 |
END MARKETING DATE: | 0000-00-00 |
LBEL LEDERM 55plus Jour SPF 15 Facial Treatment Against Advanced Signs of Aging Day – All Skin Types HUMAN OTC DRUG Details:
Item Description | LBEL LEDERM 55plus Jour SPF 15 Facial Treatment Against Advanced Signs of Aging Day – All Skin Types from Ventura International LTD. |
LABELER NAME: | Ventura International LTD. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .03; .05; .03; .05(g/g; g/g; g/g; g/g) |
START MARKETING DATE: | 2013-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 14783-019_f5ff921a-c276-4658-9cb2-95333590cd80 |
PRODUCT NDC: | 14783-019 |
APPLICATION NUMBER: | part352 |
Other AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE Pharmaceutical Manufacturers / Labelers: